<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kimura T</submitter><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>e1007674</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6453442</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(4)</volume><pubmed_abstract>Viral myocarditis is a serious disease, commonly caused by type B coxsackieviruses (CVB). Here we show that innate immune protection against CVB3 myocarditis requires the IFIT (IFN-induced with tetratricopeptide) locus, which acts in a biphasic manner. Using IFIT locus knockout (IFITKO) cardiomyocytes we show that, in the absence of the IFIT locus, viral replication is dramatically increased, indicating that constitutive IFIT expression suppresses CVB replication in this cell type. IFNβ pre-treatment strongly suppresses CVB3 replication in wild type (wt) cardiomyocytes, but not in IFITKO cardiomyocytes, indicating that other interferon-stimulated genes (ISGs) cannot compensate for the loss of IFITs in this cell type. Thus, in isolated wt cardiomyocytes, the anti-CVB3 activity of IFITs is b</pubmed_abstract><journal>PLoS pathogens</journal><pubmed_title>Biphasic and cardiomyocyte-specific IFIT activity protects cardiomyocytes from enteroviral infection.</pubmed_title><pmcid>PMC6453442</pmcid><funding_grant_id>R01 AI110621</funding_grant_id><funding_grant_id>R01 AI114615</funding_grant_id><funding_grant_id>R01 CA068782</funding_grant_id><funding_grant_id>P01 CA062220</funding_grant_id><pubmed_authors>Flynn CT</pubmed_authors><pubmed_authors>Sen GC</pubmed_authors><pubmed_authors>Kimura T</pubmed_authors><pubmed_authors>Alirezaei M</pubmed_authors><pubmed_authors>Whitton JL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biphasic and cardiomyocyte-specific IFIT activity protects cardiomyocytes from enteroviral infection.</name><description>Viral myocarditis is a serious disease, commonly caused by type B coxsackieviruses (CVB). Here we show that innate immune protection against CVB3 myocarditis requires the IFIT (IFN-induced with tetratricopeptide) locus, which acts in a biphasic manner. Using IFIT locus knockout (IFITKO) cardiomyocytes we show that, in the absence of the IFIT locus, viral replication is dramatically increased, indicating that constitutive IFIT expression suppresses CVB replication in this cell type. IFNβ pre-treatment strongly suppresses CVB3 replication in wild type (wt) cardiomyocytes, but not in IFITKO cardiomyocytes, indicating that other interferon-stimulated genes (ISGs) cannot compensate for the loss of IFITs in this cell type. Thus, in isolated wt cardiomyocytes, the anti-CVB3 activity of IFITs is b</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Apr</publication><modification>2025-04-04T13:25:22.771Z</modification><creation>2019-06-06T21:07:26Z</creation></dates><accession>S-EPMC6453442</accession><cross_references><pubmed>30958867</pubmed><doi>10.1371/journal.ppat.1007674</doi></cross_references></HashMap>